BLEOMYCIN AND CIS-PLATINUM WITH OR WITHOUT MITOMYCIN-C IN 110 PREVIOUSLY UNTREATED PATIENTS WITH HEAD AND NECK-CANCER

被引：6

作者：

ISRAEL, L

AGUILERA, J

SOUDANT, J

PENOT, JC

BREAU, JL

MORERE, JF

机构：

[1] HOP AVICENNE,DEPT OTORHINOLARYNGOL,F-93000 BOBIGNY,FRANCE

[2] CTR HOSP ORLEANS,DEPT OTORHINOLARYNGOL,ORLEANS,FRANCE

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1983年 / 6卷 / 03期

关键词：

D O I：

10.1097/00000421-198306000-00009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：305 / 311

页数：7

共 50 条

[41] COMPARATIVE TRIAL OF CIS-PLATINUM (C) ONCOVIN (O) AND BLEOMYCIN (B) VS METHOTREXATE (M) IN PATIENTS WITH ADVANCED EPIDERMOID CARCINOMAS OF THE HEAD AND NECK
BAKER, L
ALSARRAF, M
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 202 - 202
[42] COMBINED CHEMOTHERAPY WITH CIS-PLATINUM (DDP) AND BLEOMYCIN (B) IN THE MANAGEMENT OF HEAD AND NECK (H AND N) CARCINOMA
CHIESA, CJ
CINTRON, J
VELEZGARCIA, E
MALDONADO, M
SUAU, LJ
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 476 - 476
[43] THE COST AND CLINICAL-VALUE OF COMBINATION OF CIS-PLATINUM ONCOVIN AND BLEOMYCIN (COB) VS METHOTREXATE IN PATIENTS WITH ADVANCED HEAD AND NECK EPIDERMOID CANCER
ALSARRAF, M
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 354 - 354
[44] COMBINED TREATMENT WITH CHEMOTHERAPY, SURGERY, AND RADIOTHERAPY IN ADVANCED, PREVIOUSLY UNTREATED HEAD AND NECK-CANCER
ALSARRAF, M
MATHOG, R
POWERS, W
LOH, J
HOSCHNER, J
WEAVER, A
HEAD & NECK SURGERY, 1981, 3 (03): : 261 - 261
[45] SEQUENTIAL METHOTREXATE-CIS-PLATINUM PERTURBATION OF HEAD AND NECK-CANCER KINETICS
TEJADA, F
ZUBROD, CG
HEAD & NECK SURGERY, 1981, 3 (03): : 260 - 261
[46] POLAR-SOLVENTS INCREASE THE SENSITIVITY OF CULTURED HUMAN-COLON CANCER-CELLS TO CIS-PLATINUM AND MITOMYCIN-C
DEXTER, DL
DEFUSCO, DJ
MCCARTHY, K
CALABRESI, P
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 267 - 267
[47] A COMPARISON OF CIS-PLATINUM VINDESINE AND CIS-PLATINUM ETOPOSIDE COMBINED WITH RADIOTHERAPY FOR PREVIOUSLY UNTREATED LOCALIZED INOPERABLE NON-SMALL CELL LUNG-CANCER
NIITAMOKORHONEN, S
HOLSTI, P
HOLSTI, LR
PYRHONEN, S
MATTSON, K
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (07): : 1039 - 1043
[48] COMBINED MODALITY THERAPY UTILIZING A CISPLATIN COMBINATION FOR EFFECTIVE CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED HEAD AND NECK-CANCER
JACOBS, JR
KISH, J
ENSLEY, JF
AHMAD, K
WEAVER, A
CRISSMAN, J
ALSARRAF, M
AMERICAN JOURNAL OF SURGERY, 1986, 152 (04): : 451 - 455
[49] A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion
Harold J. Wanebo
James F. Belliveau
Cancer Chemotherapy and Pharmacology, 1999, 43 : 427 - 434
[50] A pharmacokinetic model and the clinical pharmacology of cis-platinum, 5-fluorouracil and mitomycin-C in isolated pelvic perfusion
Wanebo, HJ
Belliveau, JF
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (05) : 427 - 434

← 1 2 3 4 5 →